Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Reyataz“
Suchtreffer
Begriffe & Kennungen
Atazanavirsulfat
Eintrag öffnenReyataz
Eintrag öffnenReyataz · 4.1 Therapeutic indications · 1
Eintrag öffnenReyataz · 4.1 Therapeutic indications · 2
Eintrag öffnenReyataz · 4.3 Contraindications · 1
Eintrag öffnenReyataz · 4.3 Contraindications · 2
Eintrag öffnenReyataz · 4.3 · Co-administration of the PDE5 inhibitor sildenafil when used for the treatment of pulmonary arterial hypertens
Eintrag öffnenReyataz · 4.3 · Co-administration with glecaprevir/pibrentasvir fixed-dose combination (see section 4.5).
Eintrag öffnenReyataz · 4.3 · Co-administration with glecaprevir/pibrentasvir fixed-dose combination (see section 4.5).
Eintrag öffnenReyataz · 4.3 · Co-administration with grazoprevir-containing products, including elbasvir/grazoprevir fixed-dose combination
Eintrag öffnenReyataz · 4.3 · Co-administration with grazoprevir-containing products, including elbasvir/grazoprevir fixed-dose combination
Eintrag öffnenReyataz · 4.3 · Co-administration with medicinal products that are strong inducers of CYP3A4 due to the potential for loss of
Eintrag öffnenReyataz · 4.3 · Co-administration with medicinal products that are strong inducers of CYP3A4 due to the potential for loss of
Eintrag öffnenReyataz · 4.3 · Co-administration with medicinal products that are substrates of the CYP3A4 isoform of cytochrome P450 and hav
Eintrag öffnenReyataz · 4.3 · Co-administration with medicinal products that are substrates of the CYP3A4 isoform of cytochrome P450 and hav
Eintrag öffnenReyataz · 4.3 · Co-administration with simvastatin or lovastatin (see section 4.5).
Eintrag öffnenReyataz · 4.3 · Co-administration with simvastatin or lovastatin (see section 4.5).
Eintrag öffnenReyataz · 4.3 · Combination of the PDE5 inhibitor sildenafil when used for the treatment of pulmonary arterial hypertension (P
Eintrag öffnenReyataz · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenReyataz · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnen